Carregant...
Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities
Acute myocardial infarction (AMI) and the heart failure that often follows, are major causes of death and disability worldwide. As such, new therapies are required to limit myocardial infarct (MI) size, prevent adverse left ventricular (LV) remodeling, and reduce the onset of heart failure following...
Guardat en:
| Publicat a: | Pharmacol Ther |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Pergamon Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5981007/ https://ncbi.nlm.nih.gov/pubmed/29330085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2018.01.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|